Levofloxacin and Multihance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levofloxacin (levofloxacin; sodium chloride) and Multihance (gadobenate dimeglumine). Common drug interactions include general physical health deterioration among females and abasia among males.

The phase IV clinical study analyzes what interactions people have when they take Levofloxacin and Multihance. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Levofloxacin?

Levofloxacin has active ingredients of levofloxacin; sodium chloride. It is often used in sinusitis. eHealthMe is studying from 16,335 Levofloxacin users. Check the latest studies of Levofloxacin.

What is Multihance?

Multihance has active ingredients of gadobenate dimeglumine. eHealthMe is studying from 5,786 Multihance users. Check the latest studies of Multihance.



On Jul, 12, 2026

13 people who take Levofloxacin and Multihance together, and have interactions are studied.

Levofloxacin and Multihance drug interactions.

What are the common drug interactions of Levofloxacin and Multihance, by gender? *:

female:

  1. General physical health deterioration (weak health status)
  2. Mobility decreased (ability to move is reduced)
  3. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  4. Pain
  5. Pain in extremity
  6. Anxiety
  7. Arthralgia (joint pain)
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Bone pain
  10. Burning sensation

male:

  1. Abasia (inability to walk)
  2. Anxiety
  3. Oedema peripheral (superficial swelling)
  4. Pain
  5. Pain in extremity
  6. Skin hypertrophy (skin cells enlarges)
  7. Emotional distress
  8. Fear
  9. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  10. Injury

What are the common drug interactions of Levofloxacin and Multihance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Arthralgia (joint pain)
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  3. Bone pain
  4. Burning sensation
  5. Deformity (disfigurement)
  6. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  7. General physical health deterioration (weak health status)
  8. Joint stiffness
  9. Mobility decreased (ability to move is reduced)
  10. Muscular weakness (muscle weakness)

60+:

  1. Anxiety
  2. Emotional distress
  3. Fear
  4. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  5. Muscle contracture (a permanent shortening of a muscle)
  6. Muscular weakness (muscle weakness)
  7. Oedema peripheral (superficial swelling)
  8. Skin hypertrophy (skin cells enlarges)
  9. Injury
  10. Mobility decreased (ability to move is reduced)

What are the existing conditions these people have? *

  1. Nuclear Magnetic Resonance Imaging Abdominal: 5 people, 38.46%
  2. Nuclear Magnetic Resonance Imaging Brain: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Levofloxacin and Multihance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Levofloxacin and Multihance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Levofloxacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Multihance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levofloxacin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Multihance and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levofloxacin; sodium chloride and gadobenate dimeglumine (the active ingredients of Levofloxacin and Multihance, respectively), and Levofloxacin and Multihance (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: